ABBVIE INC. vs. Kazia Therapeutics Limited American Depositary Shares
ABBV
ABBVIE INC.
$255.48 -1.03%
VS KZIAKazia Therapeutics Limited American Depositary Shares
$13.58 -19.64%
ABBVIE INC. and Kazia Therapeutics Limited American Depositary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | KZIA | |
|---|---|---|
| Market Cap | $451.46 billion | $155.18 million |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | — |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | KZIA | |
|---|---|---|
| P/E Ratio | 72.17 | — |
| Price / Book | -76.68 | — |
| Price / Sales | 7.01 | — |
ABBV and KZIA split the valuation factors evenly.
Profitability
| ABBV | KZIA | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | — |
ABBV and KZIA split the profitability factors evenly.
Dividend
| ABBV | KZIA | |
|---|---|---|
| Dividend Yield | 2.71% | — |
| Payout Ratio | 195.48 | — |
ABBV and KZIA split the dividend factors evenly.
Risk & Sentiment
| ABBV | KZIA | |
|---|---|---|
| Short Interest | 0.85% | 0.04% |
KZIA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, KZIA overview, KZIA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.